Bristol-Myers (BMY), Pfizer (PFE) Report FDA Acknowledgment of ELIQUIS NDA Resubmission
Go back to Bristol-Myers (BMY), Pfizer (PFE) Report FDA Acknowledgment of ELIQUIS NDA Resubmission| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 67.01 +1.54 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.47 | 52 Week High | $77.12 | |||
| Open | $65.79 | 52 Week Low | $49.03 | |||
| Day High | $67.55 | P/E | 43.51 | |||
| Day Low | $65.13 | EPS | $1.54 | |||
| Volume | 7,932,248 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.07 +0.28 (1.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.79 | 52 Week High | $37.39 | |||
| Open | $27.77 | 52 Week Low | $28.25 | |||
| Day High | $28.43 | P/E | 17.01 | |||
| Day Low | $27.66 | EPS | $1.65 | |||
| Volume | 37,094,598 | |||||
